Introduction
Natural products and traditional Chinese medicine (TCM) are the most abundant resources of active compounds for drug discovery. Monoterpenes, for example, are dietary compounds extracted from the ethereal oils of many vegetables, fruits, and especially TCM. Geraniol ( Figure 1A ) is an acyclic monoterpene alcohol, which is found in the ethereal oils of aromatic plants. 1 Geraniol has been shown to exert a wide spectrum of pharmacological activities, for example anti-inflammatory, antimicrobial, antitumor, and so on. [2] [3] [4] [5] Close attention has been paid to geraniol due to its potential role in the treatment of a variety of diseases, such as chronic or allergic rhinitis, lung cancer, etc. [6] [7] [8] These results suggest that geraniol can be utilized as a valuable chemical probe or a chemical moiety for the dissection of complex biological processes, discovery of hidden molecular relationships, and identification of therapeutic target molecules and pathways. Accordingly, the molecular mechanisms which geraniol induces and the resulting changes in cellular phenotypes are rarely studied. Meanwhile, employment of computational methodologies for the identification of drug targets and the underlying mechanisms is becoming mainstream in order to save money, time, and effort. 9, 10 In particular, computational target identification and following the molecular mechanisms can accelerate the drug discovery and drug design processes.
Therefore, we elucidated the pharmacological actions of geraniol systematically using computational methodologies. First, the druggability of geraniol was assessed using the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) server. 11 Next the potential candidate target genes were predicted by chemical-gene interaction analysis. 12 Furthermore, gene ontology and pathway analyses were investigated using the identified target genes. Finally, drug-target network was constructed to provide a systematic overview of the potential target genes and the mechanism of action for geraniol. A schematic diagram of the analysis procedures for geraniol target gene prediction is shown in Figure 1B .
Materials and methods
Assessment of pharmacokinetics properties using TCMSP database (http://lsp.nwu.edu.cn/tcmsp.php) is a resource of systems pharmacology for TCMs or related compounds.
11
It can provide information on the absorption, distribution, metabolism, and excretion (ADME) properties of a drug with potential biological effects at a systematic level, for example, oral bioavailability (OB), drug likeness (DL), Caco-2 permeability (Caco-2), blood-brain barrier (BBB), and so on. 13, 14 Of all pharmacokinetics properties, OB is the foremost feature of orally administered drugs, since it acts as a vital role in evaluating the efficacy of the drug distribution to the systemic circulation. In TCMSP database, OB was calculated on OBioavail1.1 based on an in-house model. 11, 13 For orally administered drugs, the movement across the intestinal epithelial barrier is one of the biggest obstacles of human absorption and its bioavailability. 11, 13 In present study, the chemical name "geraniol" was entered to the search box and its pharmacokinetic properties were investigated at the molecular level.
Target identification by the Comparative Toxicogenomics Database
The Comparative Toxicogenomics Database (CTD, http:// ctdbase.org/), is a robust, publicly available database for toxicogenomic information. It provides manually curated key information about chemical-gene/protein interactions, 12 Given a compound, CTD can provide the corresponding target genes sorted by the interactions between them by descending order. Candidate targets of geraniol were predicted using CTD with default parameters.
analysis by geneMania GeneMANIA (http://www.genemania.org), is an userfriendly and flexible web server, for generating hypotheses in regard to gene function, analyzing gene lists, and prioritizing genes for functional assays. 15 Given a query list, GeneMANIA can list the genes that have shared properties, or function similarly with the original query. It also shows a functional relationship network, expounding the association among the list as well as curated genomics and proteomics data. The potential candidate target genes were entered into the search bar after selecting Homo sapiens from the organism option, and the results were further collated.
gene function and pathway enrichment analysis
Web-based gene set analysis toolkit (WebGestalt, http:// www.webgestalt.org/option.php) can be utilized to thoroughly understand the functional and pathway enrichment information on the gene of interest. 16 Potential candidate targets were input to the WebGestalt server using overrepresentation enrichment analysis method with the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases.
GO analysis is a commonly used approach for annotating genes and gene products with functions including molecular function, biological pathways, and cellular components. 17 KEGG is a useful resource for systematic analysis of gene functions and related high-level genome functional information.
18,19
Figure 2 Protein network of geraniol. Black nodes represent target proteins, and connecting colors indicate different correlations. Functional associations between targets were investigated using geneMania. genes in black circles were query terms while these in gray circle indicate genes associated with query genes.
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network construction
In order to understand the complex relationships among compound, targets, and diseases, we used Cytoscape (v 3.6.1; https://www.nigms.nih.gov/) to construct and analyze the three-layer networks.
Results
Pharmacokinetics properties of geraniol
ADME describes the disposition of a pharmaceutical compound and TCMCP provides information on 12 very important characteristics on ADME-related properties like
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11 AMDE-related properties of geraniol were thoroughly investigated using TCMSP. Notably, the OB of geraniol was calculated to be 23.93%.
Targets identification of geraniol
Potential targets of geraniol were predicted using the CTD as described in the "Materials and methods" section. 12 In total, 41 candidate target genes were identified by CTD. Afterwards, we filtered these genes by using the threshold chemical-gene interaction $1 and removed the non-human genes. Finally, 38 unique target genes for geraniol remained (Table 1 ). These 38 identified interacting genes were used for further investigation.
geneMania analysis
Among the 38 targets and their interacting proteins, it was found that 37.05% had physical interactions, 20.16% exerted co-localization, and 19.43% displayed similar coexpression characteristics. Other results, including pathway, 
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Zhang et al respectively. Today, the rule of five is generally referred to as a guideline for drug optimization. 22 As shown in Table 2 , the pharmacokinetic properties of geraniol meet these requirements, meaning geraniol is a superior candidate for drug development.
In drug discovery, target gene identification is the first step. More and more active compounds or drugs are being shown to interact with multiple genes or proteins. [23] [24] [25] [26] A variety of in silico target identification approaches have been developed and are broadly applied toward this aim. As listed in Table 1 , 38 potential targets of geraniol were identified using computational methods. The results of GeneMANIA provided information on physical interactions, co-localization, co-expression as well as shared protein domains, and implied that the targets and their interacting proteins may have identical or similar functions.
We identified an inflammatory role for geraniol in allergic rhinitis. Similarly, Madankumar et al reported geraniol exerts antimicrobial, antioxidant, antitumor, and anti-inflammatory activities via activation of apoptotic pathways. 6, 27 These results closely coincide with our findings from GO and KEGG analyses.
The drug-target network shown in Figure 5 also revealed that geraniol has multiple targets and further indicated that it possesses multiple pharmacological activities. Cho et al have also revealed that geraniol exerts systematic pharmacological effects by targeting multiple proteins and pathways. 28, 29 Multiple target therapeutic medicaments are more effective for the treatment of complex diseases, for instance allergic rhinitis, cancers, and are less vulnerable to adaptive resistance. Hence, geraniol could be a promising resource that may be utilized as chemical moiety, lead compound, or an active ingredient for future drug discovery.
In summary, we would like to underline that geraniol is an active ingredient or a promising compound for the development of a safe and effective multi-targeted anticancer medicament. This study provides novel insight into the perspectives and challenges for geraniol research and its application in future clinical investigation.
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shared protein domains and genetic interactions, are shown in Figure 2 .
gO and pathway analysis
In order to study further the 38 identified target genes, GO and KEGG enrichment analyses were carried out using WebGestalt. As shown in Figure 3 , the top seven functions were used as response to stimulus (35/38), biological regulation (33/38), metabolic process (31/38), membrane (30/38), protein binding (30/38), multicellular organismal process (29/38), and cell communication (28/38) . These functional terms are highly relevant to anti-inflammatory activities, especially for chronic or allergic rhinitis.
As for pathway analysis, the 38 targets participate in 10 KEGG pathways with significant false discovery rate (FDR)-adjusted P-value including apoptosis, pathways in cancer, and so on, which were shown in Figure 4 .
network analysis
Based on target and pathway analyses, an entire compound, targets and diseases network was constructed using Cytoscape (v 3.6.1). As shown in Figure 5 , this compound, targets, and diseases interaction network has 80 nodes and 129 edges. The red oblong, green inverted triangles, and blue circles correspond to geraniol, target genes, and pathways, respectively.
Discussion
Poor pharmacokinetics and toxicity are the most important causes of costly delays in drug discovery and development. There is, therefore, growing belief that certain features in the drug discovery process should be prioritized. 20 In silico analysis can improve predictions and pharmacokinetic modeling, as well as metabolic and toxicity endpoints; all of which accelerate and streamline the drug discovery process.
9,10
Lipinski's rule of five can identify some very important drug properties, which should be taken into account for compounds developed with the aim of oral delivery. 21 The rule of five takes into consideration molecular weights (MWs) ,500 Da, a LogP ,5, as well as numbers of hydrogen-bond donors and acceptors less than 5 and 10, 
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